MARVEL Logo+MARVEL Logo

Mitochondrial Antioxidant Therapy to Resolve Inflammation in Ulcerative Colitis

Marvel Study Overview

Marvel Study Design Overview
Lisa Derr introducing MARVEL

Introducing MARVEL

By Lisa Derr, Trial Manager

Marvel Recruitment Status

44 / 206 participants
Last updated: July 2024

Center Breakdown

Edinburgh
26
Glasgow
10
Pinderfields Hospital
4
Dundee
2
Chelsea & Westminster
1
Darlington Memorial Hospital
1
St George's
0

I'm delighted to take forward the research findings over the last 10 years from my scientific team into a human clinical trial. This has been a journey involving many scientists, clinicians and also our patients. The MARVEL study will provide very much needed data to show whether this new treatment approach will work in Ulcerative Colitis.

DR GWO-TZER HO

Chief Investigator
Centre for Inflammation Research
University of Edinburgh

Gwo Tzer Ho

Sponsors

Jon Moulton Charity Trust
Centre for Inflammation Research
NHS Lothian
ACCORD

About Us

Centre for Inflammation ResearchCentre for Inflammation Research, Queen's Medical Research Institute
Centre for Inflammation Research Site OverviewEdinburgh BioQuarter Site Overview

Dr Gwo-Tzer Ho

Chief Investigator (Marvel)

MARVEL Logo

Professor David Wilson

Chief Investigator (mini-Marvel)

MARVEL Logo

Professor Chris Probert

Chair, Trial Steering Committee

MARVEL Logo

Professor Jonathan Rhodes

Chair, Data Monitoring Committee

MARVEL Logo

Michelle Wilson

Research Associate

MARVEL Logo

Dr Rebecca Hall

Clinical Research Fellow

MARVEL Logo

Dr Shaun Chuah

Clinical Research Fellow

MARVEL Logo

Beena Pouloose

Clinical Research Nurse

MARVEL Logo

Athena Oddy

Clinical Research Nurse

MARVEL Logo

Alix MacDonald

Trial Manager

MARVEL Logo

Lisa Derr

Trial Manager

MARVEL Logo

Katherine Lewis

Trial Support Officer

MARVEL Logo